background image

Clinical Trials In Minneapolis

Discover hundreds of clinical trials in Minneapolis.
Search clinical trials in Minneapolis by condition or phase.

e.g. Respiratory Diseases
Minneapolis•Healthy volunteers: No

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Saint Paul, La Crosse, Duluth, Marshfieldshow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Minneapolis, Rochester, Fargo, Madisonshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Minneapolis, Madison, Iowa City, Milwaukeeshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

GlaxoSmithKline

Location:

Minneapolis, Mankato, Columbia, Windsorshow 35 more

Code:

NCT06261957

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Salbutamol HFA-134a

Salbutamol HFA-152a

REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1

Recruiting
PHASE2
PHASE3

Sponsor:

Sutro Biopharma, Inc.

Location:

Minneapolis, Omaha, Kettering, Cincinnatishow 22 more

Code:

NCT05870748

Conditions

Ovarian Cancer

Epithelial Ovarian Cancer

Fallopian Tube Cancer

Primary Peritoneal Cancer

Platinum-resistant Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luveltamab tazevibulin

Pegfilgrastim

Gemcitabine

Paclitaxel

Pegylated liposomal doxorubicin

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Recruiting

Sponsor:

University of Kansas Medical Center

Location:

Minneapolis, Maplewood, Sioux Falls, Kansas Cityshow 7 more

Code:

NCT06425848

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Observational

Multi-speed Ergonomic Wheelchair

Recruiting

Sponsor:

VA Office of Research and Development

Location:

Minneapolis

Code:

NCT05776030

Conditions

Spinal Cord Diseases

Spinal Cord Injuries

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single Speed Ergonomic Wheelchair

Multi-Speed Ergonomic Wheelchair

Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain

Recruiting

Sponsor:

University of Minnesota

Location:

Minneapolis

Code:

NCT04164225

Conditions

Low Back Pain

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Qigong Exercise

P.Volve Exercises

The COCOA-PAD II Trial

Recruiting
PHASE3

Sponsor:

Northwestern University

Location:

Minneapolis, Chicago

Code:

NCT04794530

Conditions

Peripheral Artery Disease

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

cocoa flavanols

placebo

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Minneapolis, Saint Louis Park, Robbinsdale, Fridleyshow 238 more

Code:

NCT03678025

Conditions

Castration Levels of Testosterone

Metastatic Prostatic Adenocarcinoma

Stage IV Prostate Cancer AJCC v8

Stage IVA Prostate Cancer AJCC v8

Stage IVB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abiraterone

Bicalutamide

Degarelix

Docetaxel

Flutamide